Alexander Introduces Pharmaceutical Compounding Legislation

Wednesday, May 15, 2013

Chairman of the Senate Health, Education, Labor and Pensions Committee Senator Tom Harkin (D-Iowa) and Ranking Member Lamar Alexander (R-Tn.), with Senators Pat Roberts (R-Ks.) and Al Franken (D-Mn.) and other members of the HELP Committee, on Wednesday introduced legislation—the Pharmaceutical Compounding Quality and Accountability Act—that would improve the safety of compounded human and animal drugs by making clear the compounding oversight responsibilities of state and federal authorities. 

Chairman Harkin and Ranking Member Alexander also announced that the Committee will convene for an executive session next Wednesday, to consider the compounding bill, along with newly-introduced legislation to strengthen and improve the drug distribution supply chain.

In April, Senators Harkin, Alexander, Roberts, and Franken released draft legislation relating to pharmaceutical compounding and requested that stakeholders provide feedback on the policy merits, potential unintended consequences, and opportunities to improve the legislative language. Additionally, the HELP Committee held a legislative hearing in early May to listen to more in-depth testimonies from experts and stakeholders to improve the draft bill.  An updated one-pager, section-by-section and the Pharmaceutical Compounding Quality and Accountability Act can be viewed on the HELP Committee website.

The Pharmaceutical Compounding Quality and Accountability Act makes a clear distinction between traditional compounding—which will continue to be regulated primarily by state pharmacy boards—and compounding manufacturers that make sterile products without, or in advance of, a prescription and sell those products across state lines. The compounding manufacturers would be regulated by the U.S. Food and Drug Administration (FDA). It clarifies a national, uniform set of rules for compounding manufacturers while preserving the states’ primary role in traditional pharmacy regulation.

“We cannot wait for the next public health crisis—as we saw with the New England Compounding Company disaster that led to more than 50 deaths and caused serious illness in 700 more—to act to improve the safety of compounded drugs,” Chairman Harkin said. “The Pharmaceutical Compounding Quality and Accountability Act will help protect the public from unsafe compounded products and clarify FDA authority over high-risk compounding practices. I am proud of the bipartisan effort that members of this Committee have put forth in drafting this bill, and I am appreciative of the helpful and constructive feedback received from stakeholders throughout this process. I look forward to considering this bill in an executive session of the Committee next week.”

Senator Alexander said, “My primary goal with this legislation is to erase the confusion over who regulates pharmacies and manufacturing facilities, and make it clear exactly who oversees each business. Putting one agency on the flagpole for each of these businesses will mean greater safety for American families, so they don’t have to question whether the drugs they take are safe.”

“I am proud of the work we have done to craft a solution that protects patients, while preserving the practice of traditional pharmacy compounding,” Senator Roberts said. “After reviewing stakeholder comments, we made a concerted effort to address their concerns in this legislation. This bipartisan bill is balanced, clear and will leave no questions about the regulatory oversight of compounded drugs. I urge my colleagues to support it.”

"We've seen far too many deaths in Minnesota, and nationwide, because some pharmacies in this country have acted more like drug manufacturers – without following rigorous safety rules that drug manufacturers must follow,” said Senator Franken. “This bipartisan legislation will keep Minnesotans safe by ensuring that drug manufacturers have appropriate oversight, and that responsible pharmacies don't see any unnecessary restrictions."

In addition to distinguishing between pharmacies and manufacturers, and clarifying proper oversight of each, the legislation sets forth requirements on compounding manufacturers. Compounding manufacturers must register with the FDA and tell the agency what products they have made; make products under a pharmacist’s oversight and in compliance with good manufacturing practices; and investigate and report when things go wrong.

The bill allows FDA to identify categories of drugs that currently cannot be safely compounded; preserves and enhances current protections regarding the ingredients from which drugs are compounded; and preserves the line between compounding manufacturers and traditional manufacturers by placing prohibitions on wholesale distribution of compounded products.

The legislation also encourages communication among states and increases communication between states and the FDA. FDA will designate a point of contact for a State Board of Pharmacy to notify the agency if it appears that a state-licensed business should be registered as a compounding pharmacy. The FDA must notify the state within 15 days if it determines that business is a compounding manufacturer.


Alexian Brothers PACE Aggressively Confronts The Flu

At PACE Chattanooga, we have always been vigilant about influenza because it is a serious threat to the life and health of our participants. Almost since our inception we have been a surveillance site for the Centers for Disease Control and Surveillance and are the only geriatric site in the state of Tennessee. We partner with the state and federal government in the prevention, ... (click for more)

Alcatraz Fitness Celebrates Grand Opening

Alcatraz Fitness announced the grand opening of their new facility located at the Cleveland/Bradley Innovation Center, 3575 Adkisson Dr., Suite 1040, Cleveland, Tn. A grand opening and ribbon cutting celebration has been scheduled for Thursday, Oct. 2.  Open house will begin at 12:30 p.m., with the official ribbon cutting taking place at 1:30 p.m.  The Cleveland/Bradley ... (click for more)

EPB Says "Close To A Wash" On City Street Light Billing

EPB President Harold DePriest denied Wednesday that EPB owes the city over $1 million on street light billing. He stated,  “EPB has never said that we owe the city $1.2 million. When all the facts are taken into account, the financial difference is close to a wash.” Mr. DePriest said, "I regret that this complicated issue has been oversimplified in some reports. As we’ve ... (click for more)

New Red Bank Zoning Ordinance Is Ready For Review

The new Red Bank zoning ordinance is ready for review, City Manager Randall Smith said Tuesday night. It can be seen on www.redbanktn.gov and the link to zoning regulations. The new ordinance will replace one that was created 30 years ago.    The plan will encompass both residential and commercial development and is intended to direct ... (click for more)

Why So Much For A Rail Study?

From the things that make you go hmm department. Ok, so the feds are giving us $400k and the city is kicking in another $300k for a total of $700k to do a study on having in town rail service. Why so much for a study? Don't get me wrong, I'm totally down with Chattanooga having some passenger trains running around. I get that. It's awesome. We've needed it for a long time. I ... (click for more)

Roy Exum: I’m Certainly No Expert

Sometime on Monday night, after I had written a piece on getting swatted with a switch as a kid, I got an email from ESPN Canada asking if I would be a televised guest on “Off the Record,” the most watched daily sports show in Canada. The subject: corporal punishment in America. Are you kidding me? I am hardly an expert. All weekend my world of sports and its excitement was warped ... (click for more)